Skip to main content
SpringerLink
Log in

The Blood-Brain Barrier: Morphology, Physiology and its Changes in Cancer Patients

  • Conference paper
Book cover Neurological Adverse Reactions to Anticancer Drugs

Part of the book series: ESO Monographs ((ESO MONOGRAPHS))

  • 29 Accesses

Abstract

It has been clear since the time of Ehrlich that the greater part of the CNS is not stained when Trypan blue is injected into the blood stream, even when other organs of the body are very heavily stained.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Goldmann EE: Vitalfarbung am Zentralnervensystem. Eimer, Berlin 1913

    Google Scholar 

  2. Pardridge WM, Oldendorf WH, Cancilla P, Frank HL: Blood-brain barrier: Interface between internal medicine and the brain. Ann Intern Med 1986 (105):82–95

    PubMed  CAS  Google Scholar 

  3. Hauw JJ, Lefauconnier JM: La barrière hématoencéphalique. I-Données morphologiques. Rev Neurol (Paris) 1983 (139):611–624

    CAS  Google Scholar 

  4. Lefauconnier JM, Hauw JJ: La barrière hématoencéphalique. II-Données physiologiques. Rev Neurol (Paris) 1984 (140):3–13

    CAS  Google Scholar 

  5. Lefauconnier JM, Hauw JJ: La barrière hématoencéphalique. III-Données physiologiques. Rev Neurol (Paris) 1984 (140):89–109

    CAS  Google Scholar 

  6. Brightman MW, Klatzo I, Olsson Y, Reese TS: The blood-brain barrier to proteins under normal and pathological conditions. J Neurol Sci 1970 (10):215–239

    PubMed  CAS  Google Scholar 

  7. Olsson Y: Vascular permeabilty in the peripheral nervous system. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R (eds) Peripheral Neuropathy, Vol 1. WB Saunders Co, Philadelphia, 1984 pp 579–597

    Google Scholar 

  8. Reese TS, Karnovsky MJ: Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967 (34):207–217

    PubMed  CAS  Google Scholar 

  9. Sternberger NH, Sternberger LA: Blood-brain barrier protein recognized by monoclonal antibody. Proc Natl Acad Sci 1987 (84):8169–7173

    PubMed  CAS  Google Scholar 

  10. Cordon-Cardo C, O’Brien JP, Casals D, Rittman Grauer L, Briedler JL, Melamed MR, Bertino JR: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989 (86):695–698

    PubMed  CAS  Google Scholar 

  11. Abott NJ: Glia and the blood-brain barrier. Nature 1987(325):195

    Google Scholar 

  12. Stewart PA, Wiley MJ: Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: A study using quail-chick transplantation chimeras. Dev Biol 1981 (84):183–192

    PubMed  CAS  Google Scholar 

  13. Janzer RC, Raff MC: Astrocytes induced blood brain barrier properties in endothelial cells. Nature 1987(325):253–257

    PubMed  CAS  Google Scholar 

  14. Raichle ME, Hartman BK, Eichling JO, Sharpe LG: Central noradrenergic regulation of cerebral blood flow and vascular permeability. Proc Natl Acad Sci 1975 (72):3726–3730

    PubMed  CAS  Google Scholar 

  15. Tengvar C, Petterson CAV, Mohammed AK, Olsson Y: Effects of the noradrenalin neurotoxin N-2 chloroethyl-2-bromo-benzylamine hydrochloride (DSP 4) on the blood-brain barrier: An experimental study in the mouse using protein tracer and density determination techniques. Acta Neuropathol 1979 (78):28–34

    Google Scholar 

  16. Harik I: Blood-brain barrier sodium/potassium pump: Modulation by central noradrenergic innervation. Proc Natl Acad Sci USA 1986 (83):4067–4070

    PubMed  CAS  Google Scholar 

  17. Estrada C, Hamed E, Krause DN: Biochemical evidence for cholinergic innervation of intracerebral blood vessels. Brain Research 1983 (266):261–270

    PubMed  CAS  Google Scholar 

  18. Felgenhauer K: The blood-brain barrier redefined. J Neurol 1986 (233):193–194

    PubMed  CAS  Google Scholar 

  19. Broadwell RD, Balin BJ, Salcman M: Transcytotic pathway for blood-borne protein through the blood brain barrier. Proc Natl Acad Sci USA 1988 (85):632–636

    PubMed  CAS  Google Scholar 

  20. Bradbury M: The concept of a blood-brain barrier. John Wiley & sons, Chichester 1979

    Google Scholar 

  21. Raichle ME, Eichling JO, Grubb RL: Brain permeability of water. Arch Neurol 1974 (30):319–321

    PubMed  CAS  Google Scholar 

  22. Walker RW, Cairncross JG, Posner JB: Cerebral herniation in patients receiving cisplatin. J Neuro Oncol 1988 (6):61–65

    CAS  Google Scholar 

  23. Wasterlain CG, Posner JB: Cerebral edema in water intoxication: I. Clinical and chemical observations. Arch Neurol 1968 (19):71–78

    PubMed  CAS  Google Scholar 

  24. Holliday MA, Kalayci MN, Harrah J: Factors that limit brain volume changes in response to acute and sustained hyper and hyponatremia. J Clin Investig 1968 (47):1916–1928

    PubMed  CAS  Google Scholar 

  25. Betz AL: Transport of ions across the blood-brain barrier. Federation Proc 1986 (45):2050–2054

    CAS  Google Scholar 

  26. Harik SI, Gravina SA, Kalaria RN: Glucose transporter of the blood-brain barrier and brain in chronic hyperglycemia. J Neurochem 1988 (51 ):1930–1936

    PubMed  CAS  Google Scholar 

  27. Kalaria RN, Gravina SA, Schmidley JW, Perry G, Harik SI: The glucose transporter of the human brain and blood-brain barrier. Ann Neurol 1988 (24)757–764

    PubMed  CAS  Google Scholar 

  28. Cremer JE, Ray DE, Sarna GS, Cunningham VJ: A study of the kinetic behaviour of glucose based on simultaneous estimates of influx and phosphorylation in brain regions of rats in different physiological states. Brain Res 1981 (221):331–342

    PubMed  CAS  Google Scholar 

  29. Gjedde A, Crone C: Blood-brain glucose transfer: repression in chronic hyperglycemia. Science 1981 (214):456–457

    PubMed  CAS  Google Scholar 

  30. Pardridge WM, Choi TB: Neutral amino acid transport at the human blood-brain barrier. Federation Proc 1986 (45):2073–2078

    CAS  Google Scholar 

  31. Hawkins AR: Transport of essential nutrients across the blood-brain barrier of individual structures. Federation Proc 1986 (45):2055–2059

    CAS  Google Scholar 

  32. Hargreaves KM, Pardridge WM: Neutral amino acid transport at the blood-brain barrier. J Biol Chem 1988 (263) :19392–19397

    PubMed  CAS  Google Scholar 

  33. Rechtand E, Rapoport SI: Regulation of the microenvironment of peripheral nerve: Role of the blood-nerve barrier. Prog Neurobiol 1987 (28):303–343

    Google Scholar 

  34. Olsson Y, Reese TS: Inaccessibility of the endoneurium of mouse sciatic nerve to exogenous proteins. Anat Rec 1969 (163):319–325

    Google Scholar 

  35. Storm AJ, Van der Kogel AJ, Nooter K: Effect of X-irradiation on the pharmacokinetics of methotrexate ion rats: Alteration of the blood-brain barrier. Eur J Cancer Clin Oncol 1985 (21):759–764

    PubMed  CAS  Google Scholar 

  36. Greig NH, Momma S, Sweeney DJ, Smith QR, Rapoport SI: Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Cancer Res 1987 (47):1571–1576

    PubMed  CAS  Google Scholar 

  37. Blasberg RG, Groothuis DR, Wright DC, Molnar P: Drug delivery to brain tumors: physiological and pharmacokinetic aspects of chemotherapy. In: Walker MD, Thomas DGT (eds) Biology of Brain tumour. Martinus Nijhoff Publishers, Boston 1986 pp 211–220

    Google Scholar 

  38. Groothuis DR, Blasberg RG: Rational brain tumor chemotherapy. The interaction of drug and tumor. Neurol Clinics 1985 (3):801–816

    CAS  Google Scholar 

  39. Levin VA: Clinical anticancer pharmacology: Some pharmacokinetics considerations. Cancer Treat Rep 1986 (13):61–76

    CAS  Google Scholar 

  40. Goldstein GW, Betz AL: Blood vessels and the blood-brain barrier. In: Asburry AK, McKhann GM, McDonald Wl (eds) Diseases of the Nervous System. William Heinemann Medical Books, London 1986 pp 172–184

    Google Scholar 

  41. Shapiro WR, Voorhies RM, Hiesiger EM, Sher PB, Basler GA, Lipschutz LE: Pharmacokinetics of tumor cell exposure to 14C-methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood tumor barriers in rat brain tumors: A quantitative autoradiographic study. Cancer Res 1988 (48):694–701

    PubMed  CAS  Google Scholar 

  42. Hiesiger EM, Basler GA, Lipschutz L, Shapiro WR: Quantitative autoradiographic (QAR) determination of 14C-PCNU concentration in C6 rat glioma after intracarotid administration. Proc Am Ass Cancer Res 1985 (26):349

    Google Scholar 

  43. Stillman MJ, Lipschutz L, Sher P, Ohnishi T, Shapiro WR: Pharmacokinetics of 195mPt-cisplatin entry into experimental rat brain tumors as measured by quantitative autoradiography. Proc Am Ass Cancer Res 1986 (27):408

    Google Scholar 

  44. Rottenberg DA, Dhawan AJL, Cooper SC, Strother N, Alcock N, Ginos JZ: Assessment of the pharmacologic advantage of intra-arterial versus intravenous chemotherapy using 13N-cisplatin and positron emission tomography: Neurology 1987 (37) Suppl 1: 335

    Google Scholar 

  45. Burger PC, Kamenar E, Schold SC, Fay JW, Phillips GL, Herzig GP: Encephalomyelopathy following high-dose BCNU therapy. Cancer 1981 (48):1318–1327

    Google Scholar 

  46. Oldendorf WH: A comparison of carotid and venous injection of antitumor agent BCNU. Trans Am Neurol Assoc 1975 (100): 225–226

    PubMed  CAS  Google Scholar 

  47. Levin VA, Kabra PM, Freeman-Dove MA: Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkey. J Neurosurg 1978 (48):587–593

    PubMed  CAS  Google Scholar 

  48. Shapiro WR, Green SB: Re-evaluating the efficacy of intra-arterial BCNU. J Neurosurg 1987 (66):313–315

    PubMed  CAS  Google Scholar 

  49. Chan PH, Longar S, Fischman RA: Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol 1987 (21):540–547

    PubMed  CAS  Google Scholar 

  50. Greer M: Carrier drugs. Neurology 1988 (38):628–632

    PubMed  CAS  Google Scholar 

  51. Reulen HJ: Vasogenic brain edema: New aspects in its formation, resolution and therapy. Br J Anaesth 1976 (48):741–752

    PubMed  CAS  Google Scholar 

  52. Tengvar C: Extensive intraneuronal spread of horseradish peroxidase from a focus of vasogenic edema into remote areas of central nervous system. Acta Neuropathol 1986 (71):177–189

    PubMed  CAS  Google Scholar 

  53. Stewart PA, Hayakawa K, Farrell CL, Del Maestro RF: Quantitative study of microvessel ultrastructure in human peritumoral brain tissue: evidence for a blood-brain barrier defect. J Neurosurg 1987 (67):697–705

    PubMed  CAS  Google Scholar 

  54. Vick NA: Brain tumor microvasculature. In: Weiss L, Gilbert HA, Posner JB (eds) Brain metastases. GK Hall & Co, Boston 1980 pp 115–133

    Google Scholar 

  55. Stewart PA, Hayakawa K, Hayakawa E, Farrell CL, Del Maestro RF: A quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model. Acta Neuropathol 1985 (67):96–102

    PubMed  CAS  Google Scholar 

  56. Blasberg R, Molnar P, Groothuis D, Patlak C, Owens E, Fenstermacher J: Concurrent measurements of blood flow and transcapillary transport in avian sarcoma virus-induced experimental brain tumors: Implications for chemotherapy. J Pharmacol Exp Therap 1984 (231):724–735

    CAS  Google Scholar 

  57. Molnar P, Blasberg RG, Horowitz M, Smith B, Fenstermacher J: Regional blood-to-tissue transport in RT-9 brain tumors. J Neurosurg 1983 (58):874–884

    PubMed  CAS  Google Scholar 

  58. Levin VA, Freeman-Dove M, Landahl HD: Permeability characteristics of brain adjacent to tumors in rats. Arch Neurol 1975 (32):785–791

    PubMed  CAS  Google Scholar 

  59. Jarden JO, Dhawan V, Poltorak A, Posner JB, Rottenberg DA: Positron emission tomographic measurement of blood-to-brain and blood-to-tumor transport of 82Rb : The effect of dexamethasone and whole-brain radiation therapy. Ann Neurol 1985 (18):636–646

    PubMed  CAS  Google Scholar 

  60. Dvorak HF: Tumors: wounds that do not heal: Similarities between tumor stroma generation and wound healing. New Engl J Med 1986 (315):1650–1659

    PubMed  CAS  Google Scholar 

  61. Ohnishi T, Shapiro WR: Increased capillary in brain produced by a soluble factor from experimental brain tumors: Possible role in cerebral edema. Proc Am Assoc Cancer Res 1987 (28):68

    Google Scholar 

  62. Bruce JN, Criscuolo GR, Merrill MJ: Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone. J Neurosurg 1987 (67):880–884

    PubMed  CAS  Google Scholar 

  63. Criscuolo GR, Merrill MJ, Oldfield EH: Further characterization of maligant glioma-derived vascular permeability factor. J Neurosurg 1988 (69):254–262

    PubMed  CAS  Google Scholar 

  64. Wahl M, Unterberg A, Baethmann A, Schilling L: Mediators of blood-brain barrier dysfunction and formation of vasogenic edema. J Cereb Blood Flow Metabol 1988 (8):621–634

    CAS  Google Scholar 

  65. Shapiro WR: A model for brain metastases. In: Weiss L, Gilbert HA, Posner JB (eds) Brain metastases. GK Hall & Co, Boston 1980 pp 134–145

    Google Scholar 

  66. Ushio Y, Chernik NL, Shapiro WR, Posner JB: Metastatic tumor of the brain: Development of an experimental model. Ann Neurol 1977 (2):20–29

    PubMed  CAS  Google Scholar 

  67. Ushio, Posner JB, Shapiro WR: Chemotherapy of experimental meningeal carcinomatosis. Cancer Res 1977 (37):1232–1237

    PubMed  CAS  Google Scholar 

  68. Ushio Y, Chernik NL, Posner JB, Shapiro WR: Meningeal carcinomatosis: development of an experimental model. J Neuropathol Exp Neurol 1977(36):224–244

    Google Scholar 

  69. Hasegawa H, Allen JC, Mehta BM, Shapiro WR, Posner JB: Enhancement of CNS penetration of methotrexate by hyperosmolar intracarotid mannitol or carcinomatous meningitis. Neurology 1979 (29):1280–1286

    PubMed  CAS  Google Scholar 

  70. Jaeckle KA, Krol G, Posner JB: Evolution of computed tomographic abnormalities in leptomeningeal metastases. Ann Neurol 1985 (17):85–89

    PubMed  CAS  Google Scholar 

  71. Sze G: MRI of tumor metastases to the leptomeninges. MRI Decisions 1988 (2):2–8

    Google Scholar 

  72. Ushio Y, Posner R, Posner JB et al: Experimental spinal cord compression caused by epidural neoplasms. Neurology 1977 (27):422–429

    PubMed  CAS  Google Scholar 

  73. Delattre J-Y, Arbit E, Thaler HT, Rosenblum MK, Posner JB: A dose-response study of dexamethasone in a model of spinal cord compression caused by epidural tumor. J Neurosurg 1989 (70):920–925

    PubMed  CAS  Google Scholar 

  74. Levin VA, Edwards MS, Byrd A: Quantitative observations of the acute effects of x-irradiation on brain capillary permeability. Int J Radiat Oncol Biol Phys 1979 (5):1627–1631

    PubMed  CAS  Google Scholar 

  75. Phillips PC, Delattre J-Y, Berger CA, Rottenberg DA: Early and progressive increase in regional brain capillary permeability following single-and fractionated-dose cranial radiation in the rat. Neurology 1987 (37) suppl 1:301

    Google Scholar 

  76. Delattre J-Y, Shapiro WR, Posner JB: Acute effects of low-dose cranial irradiation on regional capillary permeability in experimental brain tumors. J Neurol Sciences 1989 (90):147–153

    CAS  Google Scholar 

  77. Delattre J-Y, Rosenblum MK, Thaler HT, Mandell L, Shapiro WR: A model of radiation myelopathy in the rat: pathology, regional capillary permeability changes and treatment with dexamethasone. Brain 1988 (111):1319–1336

    PubMed  Google Scholar 

  78. Devinsky O, Lemann W, Evans AC, Moeller JR, Rottenberg DA: Akinetic mutism in a bone marrow transplant recipient following total-body irradiation and amphotericin B chemoprophylaxis. A positron emission tomographic and neuropathology study. Arch Neurol 1987 (44):414–417

    PubMed  CAS  Google Scholar 

  79. Neuwelt EA, Glasberg M, Frenkel E, Barnett P: Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: Neuropathological studies. Ann Neurol 1983 (14):316–324

    PubMed  CAS  Google Scholar 

  80. Neuwelt EA, Pagel M, Barnett P, Glassberg M, Frenkel EP: Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier disruption. Cancer Res 1981 (41):4466–4471

    PubMed  CAS  Google Scholar 

  81. Neuwelt EA, Barnett PA, Glasberg M, Frenkel EP: Pharmacology and neurotoxicity of cisdiaminedichloroplatinum, bleomycin, 5-fluorouracil and cyclophosphamide administration following osmotic blood-brain barrier modification. Cancer Res1983(43):5278–5285

    PubMed  CAS  Google Scholar 

  82. Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP: Effects of adrenal cortical steroids and osmotic blood-brain opening on methotrexate delivery to gliomas in the rodent: The factor of the blood-brain barrier. Proc Natl Acad Sci 1982 (79):4420–4423

    PubMed  CAS  Google Scholar 

  83. Tomiwa K, Hazama F, Mikawa H: Neurotoxicity of vincristine after the osmotic opening of the blood brain barrier. J Neuropathol Appl Neurobiol 1983 (9):345–354

    CAS  Google Scholar 

  84. Phillips PC, Dhawan V, Strother SC, Sidtis JJ, Evans AC, Allen JC, Rottenberg DA: Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: A positron emission tomographic study. Ann Neurol 1987 (21):59–63

    PubMed  CAS  Google Scholar 

  85. Hollis PH, Zappulla RA, Spigelman MK, Feuer EJ, Johnson J, Holland JF, Malis LI: Physiological and electrophysiological consequences of etoposide induced blood-brain barrier disruption. Neurosurgery 1986 (18):581–586

    PubMed  CAS  Google Scholar 

  86. Spigelman MK, Zapulla RA, Strauchen JA, Feuer EJ, Johnson J, Goldsmith SJ, Malis LI, Holland JF: Etoposide induced blood-brain barrier disruption in rats: Duration of opening and histological sequelae. Cancer Res 1986 (46):1453–1457

    PubMed  CAS  Google Scholar 

  87. Alexander JT, Saris SC, Oldfield EH: The effect of interleukin-2 on the blood-brain barrier in the 9L gliosarcoma rat model. J Neurosurg 1989 (70):92–96

    PubMed  CAS  Google Scholar 

  88. Watts RG, Wright JL, Atkinson LL, Merchant RE: Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2. Neurosurg 1989 (25):202–208

    CAS  Google Scholar 

  89. Ellison MD, Povlishock, Merchant RE : Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion. Cancer Res 1987 (47):5765–5770

    PubMed  CAS  Google Scholar 

  90. Hedley-White ET, Hsu DW: Effect of dexamethasone on blood-brain barrier in the normal mouse. Ann Neurol 1986 (19):373–377

    Google Scholar 

  91. Reid AC, Teasdale GM, McCulloch J: The effects of dexamethasone administration and withdrawal on water permeability across the blood-brain barrier. Ann Neurol 1983 (13):28–31

    PubMed  CAS  Google Scholar 

  92. Ziylan YZ, LeFauconnier JM, Bernard G, Bourre JM: Effect of dexamethasone on transport of alpha-aminoisobutyric acid and sucrose across the blood-brain barrier. J Neurochem 1988 (51):1338–1342

    PubMed  CAS  Google Scholar 

  93. Long JB, Holaday JW: Blood-brain barrier: endogenous modulation by adrenal cortical function. Science 1985 (227):1580–1583

    PubMed  CAS  Google Scholar 

  94. Eisenberg HM, Barlow CF, Lorenzo AV: Effect of dexamethasone on altered brain vascular permeability. Arch Neurol 1970 (23):18–22

    PubMed  CAS  Google Scholar 

  95. Galicich JH, French LA, Melby JC: Use of dexamethasone in treatment of cerebral edema associated with brain tumors. Lancet 1961 (81):46–53

    CAS  Google Scholar 

  96. Long DM, Hartmannn JF, French LA: The response of human cerebral edema to glucosteroid administration: An electron microscopic administration. Neurology 1966 (16):521–528

    PubMed  CAS  Google Scholar 

  97. Shapiro WR, Posner JB: Corticosteroid hormones: Effects in an experimental brain tumor. Arch Neurol 1974 (30):217–220

    PubMed  CAS  Google Scholar 

  98. Yamada K, Bremer AM, West CR: Effects of dexamethasone on tumor-induced brain edema and its distribution in the brain of monkeys. J Neurosurg 1979 (50):361–367

    PubMed  CAS  Google Scholar 

  99. Fishman RA: Steroids in the treatment of brain edema. N Engl J Med 1982 (306):359–360

    PubMed  CAS  Google Scholar 

  100. Yamata K, Ushio Y, Hayagawa T, Arita N, Yamada N, Mogami H: Effects of methylprednisolone on peritumoral brain edema: A quantitative autoradiographic study. J Neurosurg 1983 (59):612–619

    Google Scholar 

  101. Jarden JO, Dhawan V, Moeller JR, Strother SC, Rottenberg DA: The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82Rb: A positron emission tomographic study. Ann Neurol 1989 (25):239–245

    PubMed  CAS  Google Scholar 

  102. Rapoport SI: Effects of concentrated solution on blood-brain barrier. Am J Physiol 1970 (219):270–274

    PubMed  CAS  Google Scholar 

  103. Rapoport SI: Quantitative aspects of osmotic opening of the blood-brain barrier. In: Weiss L, Gilbert HA, Posner JB (eds) Brain metastases. GK Hall & Co, Boston 1980 pp 100–114

    Google Scholar 

  104. Cosolo WC, Martinello P, Louis WJ, Christophidis N: Blood brain barrier disruption using mannitol: time course and electron microscopy studies. Am J Physiol 1989 (256):R443–R447

    PubMed  CAS  Google Scholar 

  105. Koenig H, Goldstone AD, Lu CY, Trout JJ: Polyamines and Ca2+ mediate hyperosmolal opening of the blood-brain barrier: In vitro studies in isolated rat cerebral capillaries. J Neurochem 1989 (52) :1135–1142

    PubMed  CAS  Google Scholar 

  106. Hiesiger EM, Voorhies RM, Basler GA, Lipschutz LE, Posner JB, Shapiro WR: Opening the blood brain and blood-tumor barriers in experimental rat brain tumors: The effect of intracarotid hyperosmolar mannitol on capilary permeability and blood flow. Ann Neurol 1986 (19):50–59

    PubMed  CAS  Google Scholar 

  107. Warnke PC, Blasberg RG, Groothuis DR: The effect of blood-brain barrier disruption on blood-totissue transport in ENU-induced gliomas. Ann Neurol 1987 (22):300–305

    PubMed  CAS  Google Scholar 

  108. Fishman RA: Is there a therapeutic role for osmotic breaching of the blood-brain barrier ? Ann Neurol 1987 (22):300–305

    Google Scholar 

  109. Suzuki M, Iwasaki Y, Yamamoto T, Konno H, Kudo H: Sequelae of the osmotic blood-brain barrier opening in rats. J Neurosurg 1988 (69):421–428

    PubMed  CAS  Google Scholar 

  110. Neuwelt EA, Specht HD, Hill SA: Permeability of human brain tumor to 99mTc-glucoheptonate and 99mTc-albumin: Implications for monoclonal antibody therapy. J Neurosurg 1986 (65):194–198

    PubMed  CAS  Google Scholar 

  111. Neuwelt EA, Specht D, Barnett PA, Dahlborg SA, Miley A, Larson SM, Brown P, Eckerman KF, Hellström KE, Hellström I: Increased delivery of tumor specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system. Neurosurg 1987 (20):885–895

    CAS  Google Scholar 

  112. Neuwelt EA, Barnett PA, Hellström I, Hellström KE, Beaumier P, McCormick CI, Weigel RM: Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption. Cancer Res 1988 (48):4725–4729

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Neurologie, Hôpital de la Salpêtrière, Boulevard de l’Hôpital 47, 75634, Paris Cedex 13, France

    Jean-Yves Delattre

  2. Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA

    Jerome B. Posner

Authors
  1. Jean-Yves Delattre
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerome B. Posner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Service de Neurologie, Hôpital Erasme Université Libre de Bruxelles, Route de Lennik, 808, 1070, Bruxelles, Belgium

    Jerzy Hildebrand

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Delattre, JY., Posner, J.B. (1990). The Blood-Brain Barrier: Morphology, Physiology and its Changes in Cancer Patients. In: Hildebrand, J. (eds) Neurological Adverse Reactions to Anticancer Drugs. ESO Monographs. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76142-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76142-3_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76144-7

  • Online ISBN: 978-3-642-76142-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation